From: Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome
Coeff | CI- | CI+ | β | t | p | Partial r | |
---|---|---|---|---|---|---|---|
Prediction of GSRS-IBS at post-treatment. R = .536. R 2 = .287. p < .001 | |||||||
Intercept | 10.66 | −18.52 | 39.84 | 0.73 | .469 | ||
GSRS-IBS pre-treatment | 0.51 | 0.19 | 0.83 | .40 | 3.18 | .002 | .36 |
CSQ-CAT | −0.03 | −0.58 | 0.51 | -.02 | −0.10 | .921 | -.01 |
ASI | −0.01 | −0.29 | 0.27 | -.01 | −0.08 | .939 | -.01 |
IBS-QOL | −0.05 | −31.64 | 21.48 | -.08 | −0.38 | .704 | -.05 |
SDS | 0.27 | −0.23 | 0.75 | .16 | 1.08 | .284 | .13 |
Prediction of GSRS-IBS at follow-up. R = .441. R 2 = .195. p = .039 | |||||||
Intercept | 12.75 | −25.75 | 51.26 | 0.66 | .511 | ||
GSRS-IBS pre-treatment | 0.21 | −0.12 | 0.54 | .18 | 1.25 | .215 | .15 |
Major depressive disorder | 5.31 | −2.32 | 12.94 | .17 | 1.39 | .169 | .17 |
MADRS-S | 0.32 | −0.15 | 0.78 | .20 | 1.37 | .177 | .17 |
VSI | 0.08 | −0.22 | 0.38 | .11 | 0.53 | .597 | .07 |
CSQ-CAT | −0.01 | −0.59 | 0.58 | .00 | −0.02 | .985 | .00 |
IBS-QOL | 0.03 | −30.83 | 36.68 | .05 | 0.17 | .863 | .02 |
SDS | 0.04 | −0.46 | 0.54 | .03 | 0.17 | .866 | .02 |